| Dr David John Barnette Jr, MD | |
|
6649 Curlew Terrace, Carlsbad, CA 92011-3965 | |
| (858) 539-7300 | |
| (858) 539-7305 |
| Full Name | Dr David John Barnette Jr |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 39 Years |
| Location | 6649 Curlew Terrace, Carlsbad, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750372728 | NPI | - | NPPES |
| 00G585330 | Medicaid | CA | |
| A460 | Other | CHAMPUS | |
| F065 | Other | CHAMPUS | |
| P00688353 | Other | CA | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | G58533 (California) | Primary |
| Entity Name | Scripps Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822 |
News Archive
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.
Scientists have identified a surprising new role for a new type of T cell in the immune system: some of them can be activated by nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The discovery of these T cells is novel and suggests that it may be possible to treat inflammation and autoimmune diseases by targeting the nerves and the T cells. The study was published this week in Science.
Scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, in collaboration with colleagues at the Centro de Investigaciones Energ-ticas, Medioambientales y Tecnologicas (CIEMAT) in Madrid, have discovered two proteins that control when and how these stem cells switch to being skin cells.
The U.S. Food and Drug Administration today announced a new initiative to address safety problems associated with external infusion pumps, which are devices that deliver fluids, including nutrients and medications, into a patient's body in a controlled manner.
› Verified 9 days ago
| Entity Name | David J Barnette Jr A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912007758 PECOS PAC ID: 1153218326 Enrollment ID: O20050914001395 |
News Archive
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.
Scientists have identified a surprising new role for a new type of T cell in the immune system: some of them can be activated by nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The discovery of these T cells is novel and suggests that it may be possible to treat inflammation and autoimmune diseases by targeting the nerves and the T cells. The study was published this week in Science.
Scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, in collaboration with colleagues at the Centro de Investigaciones Energ-ticas, Medioambientales y Tecnologicas (CIEMAT) in Madrid, have discovered two proteins that control when and how these stem cells switch to being skin cells.
The U.S. Food and Drug Administration today announced a new initiative to address safety problems associated with external infusion pumps, which are devices that deliver fluids, including nutrients and medications, into a patient's body in a controlled manner.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David John Barnette Jr, MD Po Box 99669, San Diego, CA 92169-1669 Ph: (858) 539-7300 | Dr David John Barnette Jr, MD 6649 Curlew Terrace, Carlsbad, CA 92011-3965 Ph: (858) 539-7300 |
News Archive
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.
Scientists have identified a surprising new role for a new type of T cell in the immune system: some of them can be activated by nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The discovery of these T cells is novel and suggests that it may be possible to treat inflammation and autoimmune diseases by targeting the nerves and the T cells. The study was published this week in Science.
Scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, in collaboration with colleagues at the Centro de Investigaciones Energ-ticas, Medioambientales y Tecnologicas (CIEMAT) in Madrid, have discovered two proteins that control when and how these stem cells switch to being skin cells.
The U.S. Food and Drug Administration today announced a new initiative to address safety problems associated with external infusion pumps, which are devices that deliver fluids, including nutrients and medications, into a patient's body in a controlled manner.
› Verified 9 days ago
Dr. Atossa Audrey Stanley, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2647 Gateway Rd Ste 105-385, Carlsbad, CA 92009 Phone: 760-931-7864 |